• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质糖基化对人肾小球系膜细胞IV型胶原、基质金属蛋白酶-2、基质金属蛋白酶-9和金属蛋白酶组织抑制因子-1表达的影响。

Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells.

作者信息

Anderson S S, Wu K, Nagase H, Stettler-Stevenson W G, Kim Y, Tsilibary E C

机构信息

Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis 55455, USA.

出版信息

Cell Adhes Commun. 1996 Aug;4(2):89-101. doi: 10.3109/15419069609010765.

DOI:10.3109/15419069609010765
PMID:8937745
Abstract

Human mesangial cells grown in either 5 or 25 mM glucose were cultured on type IV collagen which had been previously control-incubated or in vitro glycated. Northern blot analysis revealed that after 3-7 days in culture mesangial cells on glycated type IV collagen expressed approximately 25-200% more alpha 1 (IV), approximately 20-50% less matrix metalloproteinase 2 (MMP-2), and 65-75% more tissue inhibitor of metalloproteinase 1 (TIMP-1). Decreased immunoreactivity (approximately 30-40%) and collagenolytic activity (approximately 10-40%) corresponding to MMP-2 was also detected in media conditioned during the third day of culture on glycated type IV collagen. These effects on cell function were related to the extent of type IV collagen modification and were similar for cells cultured in 5 or 25mM glucose. Elevated glucose (25 vrs 5 mM) increased expression of alpha 1 (IV) mRNA (approximately 40-70%) and in conjunction with matrix glycation resulted in detectable levels of MMP-9 message by northern blot although collagenolytic activity corresponding to MMP-9 was not detectable by zymography. We conclude that glucose and matrix glycation may each alter mesangial cell function, perhaps leading to an imbalance in mesangial matrix synthesis and degradation which could contribute to mesangial expansion characteristic of diabetic renal disease.

摘要

在5 mM或25 mM葡萄糖中培养的人系膜细胞,被培养在预先经对照孵育或体外糖基化的IV型胶原上。Northern印迹分析显示,在培养3 - 7天后,在糖基化IV型胶原上的系膜细胞表达的α1(IV)多约25 - 200%,基质金属蛋白酶2(MMP - 2)少约20 - 50%,金属蛋白酶组织抑制剂1(TIMP - 1)多65 - 75%。在糖基化IV型胶原上培养第三天的条件培养基中,也检测到与MMP - 2相应的免疫反应性降低(约30 - 40%)和胶原olytic活性降低(约10 - 40%)。这些对细胞功能的影响与IV型胶原修饰程度有关,对于在5 mM或25 mM葡萄糖中培养的细胞是相似的。高糖(25 mM对5 mM)增加α1(IV) mRNA的表达(约40 - 70%),并且与基质糖基化一起通过Northern印迹导致可检测水平的MMP - 9信息,尽管通过酶谱法未检测到与MMP - 9相应的胶原olytic活性。我们得出结论,葡萄糖和基质糖基化可能各自改变系膜细胞功能,可能导致系膜基质合成和降解失衡,这可能导致糖尿病肾病特征性的系膜扩张。

相似文献

1
Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells.基质糖基化对人肾小球系膜细胞IV型胶原、基质金属蛋白酶-2、基质金属蛋白酶-9和金属蛋白酶组织抑制因子-1表达的影响。
Cell Adhes Commun. 1996 Aug;4(2):89-101. doi: 10.3109/15419069609010765.
2
Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.患有进行性肾小球硬化的转基因小鼠的系膜细胞表现出稳定的表型变化,包括无法检测到基质金属蛋白酶-9以及IV型胶原增加。
Lab Invest. 1996 Dec;75(6):791-9.
3
Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP-2/TIMP-2 mRNA expression.
Nephrol Dial Transplant. 1997 Mar;12(3):443-8. doi: 10.1093/ndt/12.3.443.
4
Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.系膜糖化对基质金属蛋白酶活性的影响:在糖尿病肾病中的可能作用。
Diabetes. 2002 Aug;51(8):2612-8. doi: 10.2337/diabetes.51.8.2612.
5
Thrombin stimulates synthesis of type IV collagen and tissue inhibitor of metalloproteinases-1 by cultured human mesangial cells.凝血酶刺激培养的人系膜细胞合成IV型胶原和金属蛋白酶组织抑制剂-1。
J Am Soc Nephrol. 1999 Jul;10(7):1516-23. doi: 10.1681/ASN.V1071516.
6
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.胰腺癌中细胞外基质蛋白及细胞外基质降解蛋白酶编码基因的表达与原位定位
Int J Cancer. 1995 Aug 9;62(4):407-13. doi: 10.1002/ijc.2910620409.
7
Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.辐射诱导的皮肤纤维化来源的原代猪皮肤成纤维细胞培养物中72-kDa明胶酶(基质金属蛋白酶-2,MMP-2)、胶原酶(基质金属蛋白酶-1,MMP-1)和组织金属蛋白酶抑制剂(TIMP)的表达
J Invest Dermatol. 1994 Jun;102(6):945-50. doi: 10.1111/1523-1747.ep12384118.
8
Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.胶原蛋白降解活性降低可能是系膜基质长期扩张的一个标志。
Clin Exp Nephrol. 2004 Mar;8(1):17-26. doi: 10.1007/s10157-003-0258-7.
9
Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.熊果酸的抗侵袭活性与HT1080人纤维肉瘤细胞中基质金属蛋白酶-9(MMP-9)表达的降低相关。
Cancer Res. 1996 May 15;56(10):2281-4.
10
Glomerular endothelial cells synthesize collagens but little gelatinase A and B.肾小球内皮细胞合成胶原蛋白,但很少合成明胶酶A和B。
J Am Soc Nephrol. 1998 Nov;9(11):2040-7. doi: 10.1681/ASN.V9112040.

引用本文的文献

1
Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes.细胞外基质中特定部位的糖基化终产物修饰:乙二醛在糖尿病蛋白质损伤中的作用。
Clin Chem Lab Med. 2014 Jan 1;52(1):39-45. doi: 10.1515/cclm-2012-0818.
2
An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines.载脂蛋白 E4 片段影响脑细胞系中的基质金属蛋白酶 9、金属蛋白酶组织抑制剂 1 和细胞因子水平。
Neuroscience. 2012 May 17;210:21-32. doi: 10.1016/j.neuroscience.2012.03.013. Epub 2012 Mar 14.
3
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.
糖尿病与血管壁重塑:从机制洞察到再生疗法
Cardiovasc Res. 2008 May 1;78(2):265-73. doi: 10.1093/cvr/cvn039. Epub 2008 Feb 15.
4
Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.整合素α1β1和转化生长因子-β1在Alport肾小球发病机制中发挥不同作用,并作为代谢治疗的双重靶点。
Am J Pathol. 2000 Nov;157(5):1649-59. doi: 10.1016/s0002-9440(10)64802-x.